Table 1.
Demographics and clinical characteristics.
| HC | SCZ | SCZaff | Statistics, p-value | |
|---|---|---|---|---|
| Group size | 43 | 43 | 9 | |
| Age | 36.70 (11.04) | 38.72 (14.02) | 39.00 (12.60) | HC/SCZ: t = −0.73, p = 0.46 |
| (years) | HC/SCZaff: t = −0.54, p = 0.59 | |||
| Gender | 11/32 | 12/31 | 2/7 | HC/SCZ: χ2 = 0.06, p = 0.81 |
| (female/male) | HC/SCZaff: χ2 = 0.04, p = 0.83 | |||
| PANSS positive | – | 14.34 (4.94) | 15.78 (3.12) | SCZ/SCZaff: t = −0.75, p = 0.45 |
| PANSS negative | – | 14.45 (4.90) | 16.33 (4.45) | SCZ/SCZaff: t = −1.04, p = 0.30 |
| PANSS general | – | 28.47 (8.16) | 33.78 (8.98) | SCZ/SCZaff: t = −1.65, p = 0.10 |
| PANSS total | – | 57.53 (13.44) | 65.89 (14.93) | SCZ/SCZaff: t = −1.63, p = 0.11 |
| CPZ equiv. dose | – | 373.54 (335.70) | 375.0 (210.82) | SCZ/SCZaff: t = −0.01, p = 0.99 |
| Illness duration | – | 16.89 (12.99) | 16.10 (12.12) | SCZ/SCZaff: t = −0.84, p = 0.41 |
Data are shown as mean(standard deviation). Age, medication and illness duration differences between groups were compared using an independent samples t-test and differences in gender distribution using a chi-square test.